NCT07168369 (NutLT) is a NA clinical trial of protein and energy-rich supplement in Liver Transplant, sponsored by Centre hospitalier de l'Université de Montréal (CHUM).

Who is sponsoring NCT07168369?

NCT07168369 is sponsored by Centre hospitalier de l'Université de Montréal (CHUM).

What drugs are being tested in NCT07168369?

Interventions in NCT07168369: protein and energy-rich supplement.

What condition does NCT07168369 study?

NCT07168369 studies Liver Transplant.

Is NCT07168369 still recruiting?

NCT07168369 is currently completed. Last updated 15 September 2025.

Last reviewed 2025-09-15 · How we verify

NCT07168369: NutLT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Early Nutritional Intervention in Patients Undergoing Liver Transplantation

Completed NA Last updated 15 September 2025

What this trial tests

NA trial testing protein and energy-rich supplement in Liver Transplant in 30 participants. Completed in 6 January 2025.

Timeline

15 February 2021

Primary endpoint
6 January 2025

6 January 2025

Quick facts

Lead sponsor	Centre hospitalier de l'Université de Montréal (CHUM)
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	30
Start date	15 February 2021
Primary completion	6 January 2025
Estimated completion	6 January 2025
Sites	1 location across Canada

Drugs / interventions tested

protein and energy-rich supplement

Conditions studied

Liver Transplant — all drugs for Liver Transplant →

Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)

Who can join

18 and older, any sex, with Liver Transplant. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main goal of this clinical study is to assess the feasibility of a 12-week oral nutritional supplementation post-liver transplantation (LT). Secondary objectives includes evaluating changes in nutritional risk, muscle strength and mass, and quality of life during the pre-transplant period, as well as the intervention's potential impact post-LT. Following LT, participants are randomized to either: a control group, or an intervention group (high protein and energy oral supplement (235mL) for 12 week). Participants awaiting LT will complete questionnaires including nutritional risk (Liver Disease Undernutrition Screening Tool), muscle strength (Chair Stand Test), and quality of life (SF-36) every three months until surgery, at discharge after LT, and at 12 weeks. Muscle mass is measured by a computed tomography (CT) scan at admission for LT and at 12 weeks. Feasibility is assessed via eligibility rate, recruitment rate, target recruitment rate, protocol and intervention adherence, attrition rate, and safety.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Feasibility of Early Oral Nutritional Supplementation After Liver Transplantation: A Randomized Pilot Study.
Trigui A, Hogue C, Tremblay M, Huard G, et al · · 2026 · PMID 41930749 · DOI 10.1111/ctr.70524

Verify or expand the search:

Other recruiting trials for Liver Transplant

Currently open trials in the same condition.

NCT06254248 — Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma · Phase 2 · recruiting
NCT06832189 — EVR and EPO for Liver Transplant Tolerance · Phase 1 · recruiting
NCT07216508 — Liver Transplant CGM · recruiting
NCT07086989 — Cardiovascular Risk in Children With Chronic Conditions Study · recruiting
NCT06813508 — Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH · recruiting

Other Centre hospitalier de l'Université de Montréal (CHUM) trials

Trials by the same sponsor.

NCT06735638 — Outside the Cage (OTC) Robotic Esophagectomy · Phase 1 · not yet recruiting
NCT07533253 — Rescue Distal Thrombectomy in Treatment for Persistent Distal Occlusions · NA · not yet recruiting
NCT05225272 — Effectiveness of an Enhanced Recovery After Surgery Protocol in Patients Undergoing On-pump Cardiac Surgery · not yet recruiting
NCT07497061 — Comparison of Two Surgical Techniques for the Treatment of Trigger Fingers: Longitudinal Opening Versus Complete A1 Pull · NA · not yet recruiting
NCT07196410 — KAN-004 for Immune-Related Diarrhea or Colitis · Phase 1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07168369 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre hospitalier de l'Université de Montréal (CHUM)
Last refreshed: 15 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07168369.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing